Pricing
Neogeniqs is an enterprise platform for clinical-trial operations and the eTMF. Because no two trial programs are the same, we would rather understand yours first — then price to the suites and agents you actually use, your studies and users, and your integration and validation needs, never a one-size-fits-all tier.
Sound familiar?
You’ve been burned before: a “simple” platform deal that ballooned into per-seat surprises, a two-year lock-in, and a security review that stalled the whole thing for a quarter.
And the part no one says out loud:
It doesn't have to be this way
Start with your study and the work that's slowing you down. Pricing scopes to the agents, studies, and integrations you actually use — not seat-count games — and your data stays yours, portable, with no lock-in on your ability to leave.
Tell us about your studies and the work that is slowing you down, and we will scope a proposal to your program — the agents that fit, the integrations you need, and the validation your team expects. No public sign-up wall, and no obligation.
What you're actually paying for
You're not buying another point tool to bolt onto the stack. You're replacing the handoffs between an EDC, a CTMS, a coding tool, a statistical environment, and a separate eTMF with one agentic platform that runs — and keeps inspection-ready — the whole trial.
| Capability | Neogeniqs | eTMF / EDC incumbents | Point AI tools | DCT platforms |
|---|---|---|---|---|
| End-to-end: protocol → submission in one platform | ||||
| Agentic AI that executes work (not just advises) | ||||
| Statistical + CSR submission back-end (SDTM/ADaM/TLF, CSR) | ||||
| Continuous, one-click inspection-readiness | ||||
| Humans in control — grounded, traceable, reviewed | ||||
| Right-sized for emerging biotech & sites |
Built for your organization
Whether you run one study or a global portfolio, pricing scopes to your reality rather than forcing you into a fixed plan.
Scale agentic AI across a portfolio of studies with the governance, validation, and audit trails an inspection-ready program requires.
Run more studies per team with consistent, standards-fluent output across sponsors — priced to the studies and users you actually run.
Bring AI-assisted consent, source review, and eTMF to your site network without enterprise overhead you do not need.
Start lean with the specific agents your program needs today, and expand across the lifecycle as your pipeline grows.
What shapes your proposal
Every proposal is built from the same components — you decide how much of each your program needs.
License across any of the four suites and 37 agents — from protocol intelligence and eCRF design to SDTM/ADaM, TLF, CSR authoring, and the eTMF.
Scoped to the number of active studies and named users on your program, so cost tracks the work you do rather than a rigid seat count.
Connectivity to your EDC, RTSM/IWRS, email, validation tooling, and more — bidirectional where the underlying system supports it.
A validated (CSV / GAMP 5) environment with 21 CFR Part 11 audit trails, ISO 27001 security, and ISO 42001 AI governance.
Guided rollout, configuration to your SOPs, and an ongoing partnership through your first validated studies and beyond.
How pricing is scoped
You should be able to predict your cost and see what drives it. Here are the principles a proposal is built on — so there are no surprises after you sign.
Cost tracks the agents you deploy, the studies you run, and the integrations you need — not a rigid per-seat license that punishes you for adding a reviewer or a coordinator. Your whole team can do the work without a meter running on headcount.
Start with one high-value area — the eTMF, SDTM/ADaM and TLF, or informed-consent authoring — and expand across the lifecycle as you build confidence. You pay for what you turn on, when you turn it on.
The factors that shape a proposal are shared up front: suites and agents, active studies and named users, integrations, validation and data-residency needs, and support level. You see what drives the number before you commit to it.
As your program grows from a first-in-human study to a global portfolio, pricing grows with it in step — no forced re-platforming onto a different tier, and no penalty for success.
No lock-in
A pricing decision shouldn't feel like a trap. Ownership and portability are part of the agreement, so your leverage doesn't disappear the day you sign.
Your source data, documents, datasets, and the eTMF remain yours throughout the engagement. We are the processor; you are the controller.
If you leave, your records — including the eTMF and its 21 CFR Part 11 audit trail — are exported in full and in usable formats. Nothing is held hostage.
Deliverables follow CDISC (SDTM, ADaM, Define.xml) and the TMF Reference Model, so your outputs stay portable and inspection-ready outside the platform.
Contract length, renewal, and offboarding are discussed openly during scoping — no multi-year handcuffs disguised as a discount.
How to start
No public sign-up wall and no obligation. Here is exactly what happens from first conversation to a scoped quote.
Share the studies you run and the work that's slowing you down. We listen first — the goal is to understand your program, not to pitch a tier.
We walk through the agents that fit your pain, working on your kind of study, with honest answers including on the limits.
We support your security review and procurement process directly — questionnaires, architecture, validation, and data-residency details, under NDA.
You receive a proposal built to your suites, studies, integrations, and compliance needs — with the drivers of the number laid out plainly.
Built for regulated trials
Every agent runs inside a validated, audit-ready platform aligned to the standards clinical teams and inspectors expect.
Electronic records and signatures with full audit trails, access controls, and validation.
Good Clinical Practice, including risk-based quality management and computerized-system expectations.
Standards-based data capture, tabulation, and analysis datasets that validate clean in Pinnacle 21.
PHI safeguards, de-identification, and role-based access across the platform.
Lawful processing, data-subject rights, and EU data-residency support for global trials.
Security, availability, and confidentiality controls audited against Trust Services Criteria.
Certified information-security management system governing the whole platform.
AI management system for responsible, governed, and auditable use of AI.
Whenever you're ready, we'll put together a proposal tailored to your studies, integrations, and compliance needs — honest answers, no pressure.
